Shay Capital LLC - Sep 19, 2025 SCHEDULE 13G Report for LAVA Therapeutics NV Common shares, par value (euro) 0.12 per share (LVTX)

Filing Manager: Shay Capital LLC
Reporting Manager: Shay Capital LLC
Security: LAVA Therapeutics NV Common shares, par value (euro) 0.12 per share
Symbol: LVTX
Shares outstanding: 26.2M shares
Disclosed Ownership: 2.6M shares
Ownership: 9.9%
Form type: SCHEDULE 13G
Date filed: 9/26/2025, 04:01 PM
Date of event: Sep 19, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Shay Capital LLC	9.9%	2.6M	2.6M	0	Elan Foxman	Chief Financial Officer
Shay Capital Holdings LLC	9.9%	2.6M	2.6M	0	Elan Foxman	Chief Financial Officer